Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover study of valproic acid, levetiracetam, and lorazepam effects on cortical excitability in healthy volunteers
NL-OMON44198Recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of valproic acid, levetiracetam and lorazepam in epilepsy and amyotrophic lateral sclerosis (ALS) (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Resting motor threshold, Motor evoked potential peak-to-peak amplitude and 3 more. Started Sep 2017; status: recruiting.
02
Drugs
valproic acidlevetiracetamlorazepam
03
Conditions
epilepsyamyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NL-OMON44198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44198.